RSS

strategic collaboration

Kite and Gadeta have entered into a strategic collaboration for the development of novel gamma delta T cell receptor (TCR) therapies in various cancers. more

News

Cambridge Innovation Capital portfolio company, Microbiotica, has entered into a multi-year strategic collaboration to discover, develop and commercialise biomarkers, targets and medicines for inflammatory bowel disease (IBD) with Genentech. more

News

A multi-target strategic collaboration has been formed between drug discovery and development company, Lodo Therapeutics, and Genentech — a member of the Roche Group. more

News

Visterra and Vir Biotechnology have entered into a research collaboration, exclusive licence and option agreement for the development and commercialisation of select programmes for infectious diseases. more

News

Following disappointing announcements this week concerning the unmet primary endpoints of their Phase III trials, Merck and AstraZeneca have today revealed they are entering a strategic oncology collaboration. more

News

Biopharmaceutical company, Ablynx, and Sanofi have entered into a strategic collaboration for the development of Nanobody based therapeutics for the treatment of immune-mediated inflammatory diseases. more

News

Exscientia and GlaxoSmithKline (GSK) have entered into a strategic collaboration to apply an AI-enabled platform in the discovery of novel and selective small molecules for up to 10 disease-related targets. more

News